🇺🇸 FDA
Patent

US 7993857

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

granted A61KA61K2039/505A61K38/1709

Quick answer

US patent 7993857 (Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K38/1709, A61P, A61P43/00